Keyphrases
Randomized Controlled Trial
100%
Methylprednisolone
100%
Population Analysis
100%
Infant Cardiac Surgery
100%
Odds Ratio
81%
Blood Glucose
27%
Neonate
27%
Thrombosis
27%
Acute Kidney Injury
27%
Glucose-insulin System
18%
Placebo
18%
Hydrocortisone
18%
Cardiopulmonary Bypass
18%
Term Infants
18%
Prolonged Mechanical Ventilation
18%
Syndromic Diagnosis
18%
Systemic Inflammation
9%
Society of Thoracic Surgeons
9%
Randomized Placebo-controlled Trial
9%
Infection Rate
9%
Postoperative Outcomes
9%
Premature Infant
9%
Beneficial Effects
9%
Cardiothoracic Surgery
9%
Gestational Age
9%
Congenital Heart Surgery
9%
Heart Surgery
9%
Steroid Use
9%
European Associations
9%
Congenital Heart
9%
Significant Harm
9%
Group 13
9%
Heart Center
9%
Priming Fluid
9%
Pump Priming
9%
Medicine and Dentistry
Randomized Controlled Trial
100%
Heart Surgery
100%
Methylprednisolone
100%
Odds Ratio
81%
Placebo
27%
Neonate
27%
Thrombosis
27%
Acute Kidney Injury
27%
Blood Glucose
27%
Infection
18%
Artificial Respiration
18%
Hydrocortisone
18%
Cardiopulmonary Bypass
18%
Surgeon
9%
Infection Rate
9%
Thorax Surgery
9%
Prematurity
9%
Gestational Age
9%
Immunology and Microbiology
Methylprednisolone
100%
Glucose Blood Level
27%
Cortisol
18%
Insulin
18%
Infection
18%
Infection Rate
9%
Systemic Inflammation
9%